Table 4.
Serological results (DAT=>1; 320) of experimental leishmaniasis under treatment with chemical and immunological procedures
| Stage | Before inoculation | After inoculation (month) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before Treatment | During treatment | After treatment | |||||||||||
| Group | Before infection | After infection | |||||||||||
| 1 | 2 | 3 | 4 | 1 | 2 | 1 | 2 | 3 | 4 | ||||
| Group I | 0/3§ | 3/3 | 3/3 | 3/3 | 3/3 | 1/3 | 0/3 | 0/3 | 0/3 | 0/3 | 1/3 | ||
| Group II | 0/3 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 1/3 | 0/3 | 0/3 | 0/3 | ||
| Group III | 0/3 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 2/3 | 0/3 | 0/3 | ||
| Group IV | 0/3 | 1/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 1/3 | 1/3 | ||
| Group V | 3/3 | 2/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | 3/3 | ||
| Group VI | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 | ||
§
Number of positive/number of tested